VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ASH 2021 | Developing off-the-shelf CAR T-cells to treat multiple myeloma

Noopur Raje, MD, Massachusetts General Hospital, Boston, MA, shares an update on the latest developments regarding off-the-shelf CAR T-cell therapeutics for the treatment of multiple myeloma, commenting on toxicity issues that have recently emerged. Data from the Phase I UNIVERSAL trial (NCT04093596) of an anti-BCMA allogeneic CAR-T product will be presented at the ASH 2021 annual meeting. Several other trials are ongoing. This interview took place at the 63rd ASH Annual Meeting and Exposition congress in Atlanta, GA.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter